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Abstract
 
Introduction
We  examined  the  control  of  modifiable  risk  factors 
among a national sample of diabetic people with and with-
out lower extremity disease (LED).
 
Methods
The sample from the 1999-2004 National Health and 
Nutrition  Examination  Survey  consisted  of  948  adults 
aged 40 years or older with diagnosed diabetes and who 
had been assessed for LED. LED was defined as peripher-
al arterial disease (ankle-brachial index <0.9), peripheral 
neuropathy (≥1 insensate area), or presence of foot ulcer. 
Good control of modifiable risk factors, based on American 
Diabetes  Association  recommendations,  included  being 
a  nonsmoker  and  having  the  following  measurements: 
hemoglobin A1c (HbA1c) less than 7%, systolic blood pres-
sure less than or equal to 130 mm Hg, diastolic blood pres-
sure less than or equal to 80 mm Hg, high-density lipopro-
tein (HDL) cholesterol greater than 50 mg/dL, and body 
mass index (BMI) between 18.5 kg/m2 and 24.9 kg/m2.
 
Results
Diabetic  people  with  LED  were  less  likely  than  were 
people without LED to have recommended levels of HbA1c 
(39.3% vs 53.5%) and HDL cholesterol (29.7% vs 41.1%), 
but there were no differences in systolic or diastolic blood 
pressure, BMI classification, or smoking status between 
people with and without LED. Control of some risk factors 
differed  among  population  subgroups.  Notably,  among 
diabetic people with LED, non-Hispanic blacks were more 
likely to have improper control of HbA1c (adjusted odds 
ratio [AOR] = 2.0; 95% confidence interval [CI], 1.1-3.9), 
systolic blood pressure (AOR = 1.9; 95% CI, 1.1-3.2), and 
diastolic blood pressure (AOR = 2.6; 95% CI, 1.1-5.8), com-
pared with non-Hispanic whites.
 
Conclusion
Control of 2 of 6 modifiable risk factors was worse in dia-
betic adults with LED compared with diabetic adults with-
out LED. Among diabetic people with LED, non-Hispanic 
blacks had worse control of 3 of 6 risk factors compared 
with non-Hispanic whites.
Introduction
 
People who have diabetes are at an increased risk for 
developing lower extremity disease (LED), which includes 
peripheral arterial disease (PAD) and peripheral neuropa-
thy (PN) (1). Both conditions are associated with mobil-
ity limitations, disability, diminished quality of life and 
increased medical expenditures (2). PAD coupled with PN 
may lead to foot ulceration and ultimately nontraumatic 
amputation if not treated effectively (1). In fact, diabetic 
people with PN or PAD have been shown to be 3 times 
more likely to have an amputation compared with diabetic 
people without these conditions, and the 5-year survival 
rate  after  a  diabetes-related  amputation  has  been  esti-
mated to be less than 30% (2,3).
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 People  with  LED  are  at  increased  risk  for  coronary 
heart disease and stroke. Prospective studies have shown 
PAD, measured by the ankle-brachial index (ABI), pre-
dicts subsequent myocardial infarction and cardiovascular 
mortality (4,5). An association has also been demonstrated 
between  PN  and  cardiovascular  disease  among  people 
with diabetes (6).
 
For diabetic adults with LED, improved control of modi-
fiable risk factors may reduce the risk of progression to 
late-stage disease, which is responsible for the majority of 
health care expenditures, morbidity, mortality, and dis-
ability among people with diabetes. Lack of tightly con-
trolled blood glucose, blood pressure, and cholesterol can 
put people with diabetes at an increased risk for long-term 
complications (7,8). Furthermore, improvements in blood 
pressure and lipid control are associated with a reduction 
in adverse cardiovascular events among people with PAD, 
and reductions in blood glucose can reduce progression to 
amputation among diabetic people with PN (7,9). However, 
clinical  studies  have  shown  suboptimal  management  of 
modifiable risk factors among people with LED (10).
 
Evaluating the associations between LED and modifi-
able  risk  factors  among  diabetic  people  with  LED  may 
identify  intervention  opportunities  to  prevent  late-stage 
disease.  Our  objectives  were  to  examine  a  nationally 
representative sample of people with diagnosed diabetes 
to  1)  describe  the  prevalence  of  modifiable  risk  factors 
for people with and without LED, and 2) identify factors 
specifically associated with poor control of modifiable risk 
factors, stratified by LED presence or absence.
Methods
Data source
 
The National Health and Nutrition Examination Survey 
(NHANES) is a national population-based survey designed 
to  assess  the  health  and  nutritional  status  of  civilian, 
noninstitutionalized  people  older  than  age  2  months  in 
the United States (11). The survey consists of an in-home 
interview in which participants are queried about health 
behaviors, health status, and risk factors and includes a 
physical examination conducted at a mobile examination 
center. Beginning in 1999, NHANES has been conducted 
continuously.  We  used  data  from  NHANES  1999-2004 
in this analysis. Only people aged 40 years or older with 
diagnosed diabetes were included (n = 1,160). People with 
diabetes were defined as those with a self-report of physi-
cian-diagnosed diabetes.
 
People aged 40 years or older who completed both the in-
person interview and medical examination were assessed 
for  the  presence  of  LED,  which  included  tests  for  PAD 
and  PN,  as  well  as  physical  inspection  for  foot  lesions 
and abnormalities. Among people aged 40 years or older 
with diagnosed diabetes, 15 people with lower extremity 
amputations were excluded from analyses (1 non-Hispanic 
white, 5 non-Hispanic blacks, and 9 Mexican Americans). 
Participants with an ABI at or above 1.5 in both legs or 
in 1 leg if the ABI measurement for the opposite leg was 
missing  were  excluded  because  they  may  have  medial 
arterial perfusion, which prevents accurate ABI measure-
ment. Data on PAD for both feet were missing for 176 
participants  with  diagnosed  diabetes  (15.2%),  and  data 
on PN for both feet were missing for 55 participants with 
diagnosed diabetes (2.9%) because of equipment failure, 
participant refusal, time constraints for physical examina-
tion, inability of respondent to undergo LED assessment, 
or other unspecified cause. Thus, 984 people were assessed 
for PAD, 1,105 were assessed for PN, and of these 948 had 
an assessment for both PAD and PN (83.1% of adults aged 
≥40 with diagnosed diabetes).
 
PAD was assessed using the ABI, which is the ratio of 
systolic blood pressure in the ankles (posterior tibial ves-
sels) to that in the right arm (right brachial vessel) (Parks 
Mini-Lab IV, Model 3100, Parks Medical Electronics, Inc, 
Aloha, Oregon) (12,13). Participants aged 40 to 59 years 
had 2 blood pressure measurements taken at the right 
arm and 2 measurements taken at both the left and right 
ankles. Left and right ABI were calculated as the mean of 
the 2 measurements. People aged 60 years and older were 
only given 1 blood pressure measurement per site, and this 
single measurement was used to calculate left and right 
ABI. People with any ABI measurement (left or right) <0.9 
were considered to have PAD.
 
PN  was  assessed  by  testing  foot  sensation  with  the 
Semmes  Weinstein  monofilament  (5.07-gauge  nylon 
Semmes  Weinstein  monofilament,  Mid-Delta  Health 
Systems, Inc, Belzoni, Mississippi). Pressure was applied 
to each foot with the monofilament at 3 sites (plantar: first 
metatarsal head, fifth metatarsal head, and hallux). The 
monofilament was applied at each site until it buckled and 
then held for 1 second. A random forced-response method VOLUME 6: NO. 4
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was  used  to  determine  whether  the  participant  could 
feel  the  monofilament.  A  site  was  considered  insensate 
if a person incorrectly identified when the monofilament 
was placed on that area of the foot for 2 of 3 applications. 
Participants with 1 or more insensate area (0-6 possible) 
were  considered  to  have  PN.  Research  has  shown  1  or 
more insensate area to be predictive of amputation and 
foot ulcers, with strong specificity and sensitivity (14).
 
During the physical examination, participants’ feet were 
visually examined by health technicians for any abnormal-
ities. Participants with foot ulcers were also considered to 
have LED. Individuals with amputations (toe or foot; 1 leg 
or both legs) were excluded from analyses (n = 15) because 
they were considered to already have late-stage disease, 
and the purpose of this study is to examine prevalence of 
modifiable risk factors in earlier stages of disease (ie, PN 
and PAD).
 
Race  and  ethnicity  were  self-reported.  We  restricted 
race/ethnicity-specific  analyses  to  non-Hispanic  white, 
non-Hispanic black, and Mexican Americans due to lim-
ited  sample  size  of  other  races.  Covariates  investigated 
include age, health insurance status, sex, and education 
level. Education was categorized as high school education 
or less, including certificate of general education develop-
ment (GED), or some college or greater.
 
To evaluate control of risk factors among diabetic people 
with  LED,  the  American  Diabetes  Association  (ADA) 
Standards of Medical Care in Diabetes recommendations 
were  used  to  establish  variables  that  indicate  levels  of 
diabetic  control  (15),  including  glycemic  control  (hemo-
globin A1c [HbA1c] <7% indicative of good control) and 
blood pressure control (systolic blood pressure ≤130 mm 
Hg and diastolic blood pressure ≤80 mm Hg indicative of 
good control). Smoking is a known risk factor for LED, 
and the ADA recommends not smoking as a part of good 
disease  management  (15,16).  Participants  were  classi-
fied as never, former, or current smokers. Never smokers 
were defined as people who reported to not be currently 
smoking and to have smoked fewer than 100 cigarettes 
during their lifetime. Blood lipid control was assessed by 
measuring high-density lipoprotein (HDL) cholesterol. The 
ADA considers HDL cholesterol greater than 50 mg/dL as 
the low-risk lipid level for adults. (Low-density lipopro-
tein cholesterol [LDL] is the primary ADA-recommended 
blood lipid for assessment of blood lipid control and treat-
ment. However, due to sample size limitations during the 
study period, LDL measures were not available for these 
analyses, so HDL cholesterol was used.) Weight level was 
investigated as well, as this has been associated with some 
forms of LED among people with diabetes as well as car-
diovascular disease risk (15,17). Weight level was assessed 
by  using  body  mass  index  (BMI)  (18.5-24.9  kg/m2  = 
healthy body weight; 25.0-29.9 kg/m2 = overweight; ≥30.0 
kg/m2 = obese). The ADA recommends weight loss for all 
overweight and obese people with diabetes and considers 
it a therapeutic objective (15).
Statistical analyses
 
All  estimates  were  weighted  using  NHANES  sample 
weights. SAS version 9.1.3 (SAS Institute Inc, Cary, North 
Carolina) was used for data management, and SUDAAN 
version  9  (RTI  International,  Research  Triangle  Park, 
North Carolina) was used to account for the complex sam-
pling scheme. P values <.05 were considered statistically 
significant, with no adjustment for multiple comparisons. 
We calculated the prevalence of modifiable risk factors by 
LED status and tested for significant differences using χ2 
tests. Prevalence estimates were age-standardized to the 
2000 US population, using the following age groups: 40-
49 years, 50-64 years, and 65 years and older. To identify 
factors associated with poor control of modifiable risk fac-
tors, logistic regressions stratified by absence or presence 
of LED were used to model the odds of poor control for 
each modifiable risk factor (ie, HbA1c, systolic blood pres-
sure, diastolic blood pressure, HDL cholesterol, BMI, and 
smoking status). Variables included in the models were 
age, sex, race/ethnicity, education level, and health insur-
ance status. Adjusted odds ratios (AORs) and confidence 
intervals (CIs) were used to determine significance. If the 
CI did not include 1, the associated AOR was considered 
significant.  For  logistic  modeling,  obese  and  overweight 
categories  were  grouped  and  compared  with  normal 
weight, and never and former smokers were grouped and 
compared  with  current  smokers.  Two-way  interactions 
were examined for sex and race/ethnicity; education level 
and race/ethnicity; and sex and education level.
Results
 
Of 948 eligible participants, 365 had LED. Data on LED 
were  missing  for  212  diabetic  people  aged  40  years  or 
older. Compared with respondents without missing LED 
data,  those  with  missing  LED  information  were  more VOLUME 6: NO. 4
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likely to have less than a high school education (46.6% vs 
29.8%, P < .001), more likely to be female (61.1% vs 47.8%, 
P = .02), and more likely to be older than age 70 (56.0% vs 
42.1%, P < .001) (data not shown).
 
Approximately 35% of diabetic people aged 40 years or 
older had LED. Among people with diabetes, 33.4% of non-
Hispanic whites, 38.9% of non-Hispanic blacks and 31.9% 
of Mexican Americans had LED (Table 1).
 
The prevalence of 4 of 6 risk factors did not differ signifi-
cantly between those with and without LED: systolic blood 
pressure at or above 130 mm Hg, diastolic blood pressure 
at or above 80 mm Hg, obese BMI, and current smoking 
(Table 2). However, the prevalence of 2 risk factors was 
significantly  higher  in  people  with  LED  than  in  those 
without LED: HbA1c of 7% or higher (60.7% vs 46.5%) and 
HDL cholesterol at or below 50 mg/dL (70.3% vs 58.9%).
 
Among diabetic adults with LED, non-Hispanic blacks 
were significantly more likely than non-Hispanic whites to 
have HbA1c levels at or above 7%, systolic blood pressure 
values at or above 130 mm Hg, and diastolic blood pres-
sure values at or above 80 mm Hg (Table 3). No signifi-
cant differences were found between non-Hispanic blacks 
and non-Hispanic whites with LED for HDL cholesterol 
control, smoking status, or weight level. No differences in 
diabetic control were found between non-Hispanic whites 
and Mexican Americans with LED.
 
Racial/ethnic differences in diabetes control were also 
observed  among  diabetic  people  without  LED.  Non-
Hispanic blacks without LED were more likely to have 
uncontrolled diastolic blood pressure control (AOR = 2.2; 
95%  CI,  1.0-4.5)  compared  with  non-Hispanic  whites. 
Among those without LED, Mexican Americans were more 
likely to have HbA1c at or above 7% (AOR = 2.7; 95% CI, 
1.8-4.1) compared with non-Hispanic whites. No signifi-
cant associations were found between race/ethnicity and 
systolic blood pressure, HDL cholesterol, smoking behav-
ior, or weight control for respondents without LED.
 
Sex and education level differences in risk factor control 
according  to  LED  status  were  also  observed  in  logistic 
modeling.  Among  people  with  and  without  LED,  men 
were more likely to have HDL cholesterol at or below 50 
mg/dL after adjusting for age, race/ethnicity, health insur-
ance status, and education level (Table 3). Compared with 
people with some college education or greater, people with-
out LED who had less than a high school education were 
more likely to have poor HDL and systolic blood pressure 
control. Among participants with LED, people who had 
less than a high school education were more likely than 
those with some college education or greater to be current 
smokers.
Discussion
 
Approximately one-third of participants aged 40 years 
or older with diabetes had LED. A similar prevalence of 
risk  factor  control  at  the  ADA-recommended  level  was 
observed in participants with and without LED for 4 of 6 
measures (systolic blood pressure, diastolic blood pressure, 
BMI, and smoking status). People with LED had a signifi-
cantly lower prevalence of risk factor control at the ADA 
recommended level compared with those without LED in 
2 of 6 measures (HbA1c and HDL cholesterol).
 
In our study, people with LED were less likely to have 
tight glycemic and lipid control than were those without 
LED. Although incomplete success controlling these risk 
factors  was  observed  in  both  groups,  the  implications 
may be worse for people with LED because they are at 
increased risk for cardiovascular events and amputation. 
Poor glycemic control has been associated with increased 
susceptibility  to  foot  infection  and  poor  wound  healing 
among people with diabetes (18,19), and poor lipid control 
and poor glycemic control have been associated with car-
diovascular mortality (20). Therefore, efforts to improve 
glycemic control of blood lipids among diabetic people with 
early stage LED may be an effective strategy in reducing 
subsequent amputations and cardiovascular events.
 
Among participants with LED, we found racial/ethnic 
differences  in  the  level  of  a  few  risk  factors  that  could 
influence progression to amputation and other cardiovas-
cular outcomes. Non-Hispanic blacks were less likely to 
have adequate glycemic control and blood pressure control 
than were non-Hispanic whites, but no differences were 
observed  for  HDL  control.  Unlike  non-Hispanic  blacks, 
Mexican Americans had no differences in level of risk fac-
tor control among people with LED compared with non-
Hispanic whites.
 
Racial/ethnic differences in late-stage disease have been 
observed.  Data  from  the  National  Hospital  Discharge 
Survey  have  shown  that  whites  with  diabetes  have  a VOLUME 6: NO. 4
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lower rate of nontraumatic amputations than do blacks 
with diabetes (21). Additionally, higher rates of lower limb 
amputation have been shown to be directly attributable 
to  peripheral  vascular  disease  among  blacks  compared 
with whites (22). Differences in disease control may play 
a role in the racial/ethnic differences in amputation rates 
(23,24). Racial/ethnic differences in cardiovascular disease 
have also been documented. Compared with non-Hispanic 
whites with diabetes, non-Hispanic blacks with diabetes 
have  higher  rates  of  hospitalizations  for  cardiovascular 
events  (25).  Racial/ethnic  differences  observed  in  risk 
factor control may be associated with subsequent racial/
ethnic differences in late-stage disease. Although the find-
ings from our study do not provide direct support for that 
association, they do suggest that future studies aimed at 
clarifying  potential  racial/ethnic  differences  in  diabetes 
control may be warranted.
 
Low education level was associated with an increased 
risk  for  poor  control  of  modifiable  risk  factors  among 
people with and without LED. This finding is similar to 
those of previous reports that have documented a higher 
prevalence of cardiovascular disease risk factors in people 
with less than high school education compared with people 
with some college education or greater (26,27).
 
Our  findings  have  implications  for  national  diabetes 
objectives. Healthy People 2010 has established objectives 
to reduce the rate of lower extremity amputations in people 
with  diabetes  and  to  reduce  deaths  from  cardiovascular 
disease in people with diabetes (28). Interventions focused 
on  risk  factor  reduction  among  diabetic  people,  espe-
cially those with LED, may contribute to reducing lower 
extremity  amputations  and  cardiovascular  disease  and 
help achieve Healthy People 2010 objectives. Our findings 
also reinforce the importance of the Control your Diabetes 
for  Life  national  education  message  promoted  by  the 
National Diabetes Education Program, American Diabetes 
Association,  and  American  College  of  Cardiology,  which 
encourages  diabetes  patients  to  maintain  recommended 
levels of HbA1c, blood pressure, and cholesterol (29).
 
Our study has several limitations. First, only noninva-
sive tests were used to measure PAD and PN. Although 
more comprehensive tests may provide more accurate diag-
nostic testing, both the ABI test for PAD and the monofila-
ment test for PN have been shown to have high degrees of 
both sensitivity and specificity (13). Additionally, the ADA 
recommends  annual  foot  examinations  that  include  PN 
testing with the monofilament and PAD testing with the 
ABI, and cutpoints for PAD and PN determination were 
based  on  clinical  practice  guidelines  and  epidemiologic 
studies (13-15). Second, we used HDL cholesterol to assess 
blood lipid control, but LDL cholesterol is the current pre-
ferred measure for assessment of blood lipid control and 
treatment. Third, physical activity level is associated with 
cardiovascular disease, but we did not analyze it as a risk 
factor because clinical recommendations for physical activ-
ity by diabetic people with LED have not been established 
(15). Furthermore, it is not known whether physical activ-
ity (especially weight-bearing activity) is contraindicated 
and therefore not promoted by health care providers for 
diabetic people with severe LED. Fourth, medication data 
were not used in these analyses. It was difficult to assess 
whether  medications  were  appropriate  for  respondents’ 
diabetic management needs, so interpreting these findings 
would be problematic. Fifth, data on LED were missing for 
approximately 12% of the sampled people aged 40 or older 
with diabetes. People with missing PAD data were more 
likely to be female, older, and have less than a high school 
education. These differences may have biased our results 
because  increasing  age  and  lower  socioeconomic  status 
have  been  linked  to  worse  diabetes  outcomes.  Finally, 
NHANES  does  not  include  institutionalized  people  (eg, 
nursing home residents), and findings that include insti-
tutionalized people may differ from ours.
 
Our  study  provides  the  first  estimates  of  modifiable 
risk factors among diabetic people with and without LED 
using  nationally  representative  data.  Our  data  show  a 
higher prevalence of 2 of 6 modifiable risk factors studied 
that may affect progression to late-stage disease among 
diabetic adults with LED compared with those without 
LED. Our findings also show different levels of risk factor 
control for some risk factors among racial/ethnic groups 
with diabetes and LED. Exploring the potential role of risk 
factor control among people with LED may reduce ampu-
tations and cardiovascular events and may help explain 
and possibly reduce the observed racial/ethnic disparity in 
amputations.
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Tables
Table 1. Characteristics of People With Diagnosed Diabetes 
Aged 40 Years or Older, by LED Status, National Health and 
Nutrition Examination Survey, 1999-2004a
Characteristic
LED Present  
(N = 365)
LED Absent  
(N = 583)
P 
Valueb
Age, mean (SE) 6.8 (0.92) 9.0 (0.4) <.00
Sexc, % (95% CI)
Male 64.6 (.4-2.8) 48.2 (4.2-.2)
<.00
Female .4 (2.2-44.6) .8 (46.8-6.8)
Educationc, % (95% CI)
Less than high 
school education
0. (2.9-4.2) 2. (2.8-29.)
.0
High school or 
GED
2. (2.-4.8) 2. (9.-29.0)
Some college or 
greater
.2 (28.0-4.6) 0.8 (4.2-6.)
Health insurance, % (95% CI)
Present 9.4 (88.8-96.2) 88. (84.9-9.)
.40
Absent 6.6 (.8-.2) . (8.-.)
Race/ethnicityc, % (95% CI)
Non-Hispanic 
white
2. (62.9-80.) 4. (6.4-80.)
.2 Non-Hispanic 
black
8. (2.-26.6) . (.-26.6)
Mexican American 8.8 (.2-4.) 9.8 (6.4-4.8)
 
Abbreviations: LED, lower extremity disease; SE, standard error; CI, confi-
dence interval; GED, general education development certificate. 
a Weighted estimates. 
b P values derived from χ2 test. 
c Age-standardized to the 2000 US population.VOLUME 6: NO. 4
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Table 2. Prevalence of Modifiable Risk Factors for People With Diagnosed Diabetes Aged 40 Years or Older, by LED Status, 
National Health and Nutrition Examination Survey, 1999-2004a 
Modifiable Risk Factors
Sample Sizeb 
(N = 948)
LED Present 
(N = 365), % (95% CI)
LED Absent 
(N = 583), % (95% CI) P Valuec
HbA1c, %
< 48 9. (.-4.8) . (48.2-8.6)
.0
≥7 48 60. (2.-68.) 46. (4.4-.8)
Systolic blood pressure, mm Hg
<0 40 .8 (42.2-6.) 49.2 (42.-.8)
.0
≥130 4 48.2 (8.-6.2) 0.8 (4.8-.)
Diastolic blood pressure, mm Hg
<80 40 . (64.0-8.) 4.2 (68.-9.2)
.80
≥80 9 26. (8.-6.0) 2.8 (20.8-.)
HDL cholesterol, mg/dL
>0 6 29. (20.-4.2) 4. (4.-48.0)
.04
≤50 60 0. (8.8-9.) 8.9 (2.0-6.)
BMI classificationd
Healthy 49 2. (.-2.0) .6 (.2-2.0)
.09 Overweight  29.2 (2.-8.9) . (2.2-8.9)
Obese 40 8. (48.-6.4) 0. (42.9-8.6)
Smoking statusd
Never 4 40.9 (.-48.8) 4. (4.0-4.)
.4 Former  .8 (2.0-4.) 2.8 (28.0-.9)
Current 60 2. (6.8-6.) 9. (6.-24.)
 
Abbreviations: LED, lower extremity disease; CI, confidence interval; HbAc, hemoglobin Ac; HDL, high-density lipoprotein; BMI, body mass index. 
a Age-standardized to the 2000 US population; percentages are weighted. 
b Some cell sample sizes may not add to 948 because of missing data. 
c P values derived from χ2 test. 
d See Methods section for subgroup definitions. VOLUME 6: NO. 4
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Modifiable Risk Factor
LED Present, 
AORa (95% CI)b
LED Absent, AORa 
(95% CI) b
HbA1c ≥7%   
Sex   
Female  [Reference]  [Reference]
Male 0.9 (0.-.8) 0.8 (0.-.)
Race/ethnicity   
Non-Hispanic white  [Reference]  [Reference]
Non-Hispanic black 2.0 (.-.9) .6 (.0-2.)
Mexican American . (0.-2.) 2. (.8-4.)
Education   
Some college or greater  [Reference]  [Reference]
Less than high school . (0.6-.9) . (0.-2.4)
High school graduate or GED . (0.-.) 0.9 (0.-.9)
Health insurance coverage   
Absent  [Reference]  [Reference]
Present 0.8 (0.-2.) 0.9 (0.-2.4)
Systolic blood pressure ≥130 mm Hg   
Sex   
Female  [Reference]  [Reference]
Male 0.6 (0.-.) 0.8 (0.-.)
Race/ethnicity   
Non-Hispanic white  [Reference]  [Reference]
Non-Hispanic black .9 (.-.2) . (0.8-2.)
Mexican American 0.9 (0.-.9) 0.8 (0.4-.6)
Education   
Some college or greater  [Reference]  [Reference]
Less than high school .6 (0.-.) .9 (.-.)
High school graduate or GED 0.8 (0.-.) . (0.8-.)
Health insurance coverage   
Absent  [Reference]  [Reference]
Present . (0.-4.) . (0.6-2.8)
Modifiable Risk Factor
LED Present, 
AORa (95% CI)b
LED Absent, AORa 
(95% CI) b
Diastolic Blood Pressure ≥80 mm Hg
Sex
Female  [Reference]  [Reference]
Male .8 (0.-4.) . (0.8-.0)
Race/ethnicity
Non-Hispanic white  [Reference]  [Reference]
Non-Hispanic black 2.6 (.-.8) 2.2 (.0-4.)
Mexican American 0.4 (0.-.8) .2 (0.-2.8)
Education
Some college or greater  [Reference]  [Reference]
Less than high school .4 (0.-4.) . (0.9-.)
High school graduate or GED 0.4 (0.-.) .6 (0.-.9)
Health insurance coverage
Absent  [Reference]  [Reference]
Present 0.2 (0.-.) 0. (0.2-.)
HDL ≤50 mg/dL   
Sex   
Female  [Reference]  [Reference]
Male .2 (.4-.4) 2. (.4-.)
Race/ethnicity   
Non-Hispanic white  [Reference]  [Reference]
Non-Hispanic black 0.4 (0.-.) .0 (0.-.9)
Mexican American 0.6 (0.2-.9) 0. (0.2-2.0)
Education   
Some college or greater  [Reference]  [Reference]
Less than high school 0.8 (0.-2.2) 2.0(.-.9)
High school graduate or GED 0. (0.-.) .4 (0.-2.9)
Health insurance coverage   
Absent  [Reference]  [Reference]
Present 0.2 (0.-0.9) 2.4 (0.-8.)
Table 3. Odds of Modifiable Risk Factors for Adults With Diagnosed Diabetes, by LED Status, National Health and Nutrition 
Examination Survey, 1999-2004 
Abbreviations: LED, lower extremity disease; AOR, adjusted odds ratio; CI, confidence interval; HbAc, hemoglobin Ac; GED, general educational development 
certificate; HDL, high-density lipoprotein. 
a All models adjusted for age. 
b Confidence intervals may begin with  because of rounding. 
c See Methods section for definitions.
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Modifiable Risk Factor
LED Present, 
AORa (95% CI)b
LED Absent, AORa 
(95% CI) b
Current smoker   
Sex
Female  [Reference]  [Reference]
Male 2. (0.9-8.0) .0 (0.6-.)
Race/ethnicity   
Non-Hispanic white  [Reference]  [Reference]
Non-Hispanic black 0.8 (0.-2.0) .8 (.0-.)
Mexican American 0.4 (0.2-.8) 0. (0.-.)
Education   
Some college or greater  [Reference]  [Reference]
Less than high school 4. (.8-.2) .6 (0.8-.0)
High school graduate or GED .4 (0.-.4) .9 (.0-.6)
Health insurance coverage   
Absent  [Reference]  [Reference]
Present 0.4 (0.-.8) 0. (0.2-.2)
Modifiable Risk Factor
LED Present, 
AORa (95% CI)b
LED Absent, AORa 
(95% CI) b
Overweight or obesec   
Sex
Female  [Reference]  [Reference]
Male .0 (0.4-2.) 0.8 (0.4-.4)
Race/ethnicity   
Non-Hispanic white  [Reference]  [Reference]
Non-Hispanic black 0. (0.-.8) .8 (0.9-.4)
Mexican American 0.4 (0.2-.0) .4 (0.-2.9)
Education   
Some college or greater  [Reference]  [Reference]
Less than high school 0.4 (0.-.) .9 (.0-.8)
High school graduate or GED 0. (0.-.0) .6 (0.8-.)
Health insurance coverage   
Absent  [Reference]  [Reference]
Present .0 (0.2-.) 2.4 (.0-.8)
Abbreviations: LED, lower extremity disease; AOR, adjusted odds ratio; CI, confidence interval; HbAc, hemoglobin Ac; GED, general educational development 
certificate; HDL, high-density lipoprotein. 
a All models adjusted for age. 
b Confidence intervals may begin with  because of rounding. 
c See Methods section for definitions.
Table 3. (continued) Odds of Modifiable Risk Factors for Adults With Diagnosed Diabetes, by LED Status, National Health and 
Nutrition Examination Survey, 1999-2004 